Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple MyelomaByJason M. BroderickDecember 12th 2025
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMMLByBridget HoytDecember 11th 2025
Progression Occurs Early in R/R LBCL Treated With Epcoritamab, GlofitamabByBridget HoytDecember 10th 2025
Practical Tactics and Patient Trust With an Integrative Oncology PAByPatricia Jakel, MN, RN, AOCN,Stephanie Desrosiers, DNP, MSN, RN, AOCNS, BMTCN,Lillian Rodich, PA-C, MPHDecember 10th 2025